This opportunity is no longer accepting applications.
grant RFA-DA-25-049

Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)

This grant is for creating new solutions to enhance health outcomes and lessen negative health impacts for people who use drugs. The solutions should be budget-friendly and easy to access, ideally integrating with mobile community-based care systems to reach vulnerable and underserved populations who rarely engage with traditional healthcare. Innovations can be entirely new or adaptations of e…

This funding opportunity calls for developing novel solutions targeted to improve health outcomes and reduce the impact of adverse health consequences in people who use drugs. These solutions should maximize accessibility and affordability, ideally designed to be implemented in mobile community-…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse

Dates

Opportunity Released: June 13, 2024
Open for Submission: June 13, 2024
Submission Deadline: December 2, 2024
Application Window Closes: December 2, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.